Pharmaceuticals (22) | Guaranty Agreements (22)
Browse by Company
-
Acreage Holdings, Inc. (1)
-
ADIAL PHARMACEUTICALS, INC. (1)
-
AERIE PHARMACEUTICALS INC (1)
-
Amneal Pharmaceuticals, Inc. (1)
-
Boston Therapeutics, Inc. (1)
-
Canbiola, Inc. (3)
-
Cannabics Pharmaceuticals Inc. (1)
-
CARDAX, INC. (2)
-
Jaguar Health, Inc. (1)
-
KEMPHARM, INC (1)
-
Medicine Man Technologies, Inc. (1)
-
MYnd Analytics, Inc. (2)
-
ProPhase Labs, Inc. (1)
-
resTORbio, Inc. (2)
-
Terra Tech Corp. (2)
-
Urovant Sciences Ltd. (1)
Recent Contracts
-
Guaranty dated June 10, 2022
(ProPhase Labs, Inc., Filed With SEC on June 13, 2022)
-
Peoples Guaranty, dated November 22, 2021
(Terra Tech Corp., Filed With SEC on November 29, 2021)
-
Form of Guaranty
(Terra Tech Corp., Filed With SEC on November 29, 2021)
-
Affirmation and Amendment of Guaranty, dated October 21, 2021
(resTORbio, Inc., Filed With SEC on October 25, 2021)
-
Guaranty, dated June 25, 2021, by each of the Companys subsidiaries in favor of HT Investments MA LLC, in its capacity as collateral agent
(Boston Therapeutics, Inc., Filed With SEC on June 29, 2021)
-
2021 Addendum to Arena Guaranty Agreement from Company Subsidiaries
(Canbiola, Inc., Filed With SEC on May 21, 2021)
-
Arena Guaranty Agreement from Company Subsidiaries
(Canbiola, Inc., Filed With SEC on April 14, 2021)
-
Parent Guaranty, dated February 26, 2021, between Medicine Man Technologies, Inc, as guarantor, and GGG Partners LLC, as collateral agent
(Medicine Man Technologies, Inc., Filed With SEC on March 4, 2021)
-
Guaranty dated December 9, 2020 by Emmaus Life Sciences, Inc. in favor or Prestige Capital, Inc
(MYnd Analytics, Inc., Filed With SEC on February 22, 2021)
-
Guaranty dated February 1, 2021 by Emmaus Life Sciences, Inc. in favor of the holders of Amended and Restated 10% Senior Secured Convertible Debentures of EMI Holding, Inc
(MYnd Analytics, Inc., Filed With SEC on February 22, 2021)
